Abstract
The leading factor contributing to amputation in diabetes is usually diabetic foot disease and ulceration. The optimal approach to the management of complications of the lower limb in diabetes lies in prevention through the implementation of screening programs aimed at the early detection of neuropathy, ischemia, deformity, and edema. However, even with aggressive screening, chronic ulceration of the lower limbs remains one of the most common and serious consequences of diabetes. Understanding the causes of diabetic foot ulceration is critical to supplement traditional management approaches. In diabetes, recent evidence suggests that skin structural and functional deficits may contribute to the risk of developing foot ulceration. In diabetes, oxidative and nitrosative stress are implicated in the development of wide-ranging complications including neuropathy, and evidence is accumulating that it may play an important role in the development of skin structural and perfusion deficits, foot ulceration, and impaired wound healing. Better understanding of the causes of these deficits may offer the opportunity to develop new therapeutic approaches which may ultimately reduce the risk of developing this common and disabling complication of diabetes.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Edmonds ME (2004) The diabetic foot. Diabetes Metab Res Rev 20(Suppl 1):S9–S12
Boulton AJ, Kirsner RS, Vileikyte L (2004) Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 351:48–55
Golinko MS, Margolis DJ, Tal A et al (2009) Preliminary development of a diabetic foot ulcer database from a wound electronic medical record: a tool to decrease limb amputations. Wound Repair Regen 17:657–665
Pecoraro RE, Reiber GE, Burgess EM (1990) Pathways to diabetic limb amputation. Basis for prevention. Diabet Care 13:513–521
Reiber GE (1996) The epidemiology of diabetic foot problems. Diabet Med 13(Suppl 1):S6–S11
Lavery LA, Armstrong DG, Wunderlich RP et al (2003) Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabet Care 26:1435–1438
Reiber GE (2001) Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA (eds) The diabetic foot. Mosby, St Louis, pp 13–32
Gregg EW, Sorlie P, Paulose-Ram R et al (2004) Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999–2000 national health and nutrition examination survey. Diabetes Care 27:1591–1597
Vileikyte L (2001) Diabetic foot ulcers: a quality of life issue. Diabetes Metab Res Rev 17:246–249
Carrington AL, Mawdsley SK, Morley et al (1996) Psychological status of diabetic people with or without lower limb disability. Diabetes Res Clin Pract 32:19–25
Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293:217–228
Edmonds ME (1987) Experience in a multidisciplinary diabetic foot clinic. In: Connor H, Bouton AJM, Ward JD (eds) The foot in diabetes: proceedings of the first national conference on the diabetic foot, Malvern, May 1986. Wiley, Chicester, pp 121–134
Boulton AJM (1990) The diabetic foot: neuropathic in aetiology? Diabet Med 7:852–858
Ctercteko GC, Dhanendran M, Hutton WC et al (1981) Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 68:608–614
Brand PW (1998) Repetitive stress in the development of diabetic foot ulcers. In: Levin ME, O’Neal LW (eds) The diabetic foot, 4th edn. CV Mosby, St. Louis, pp 83–90
Gibbons GW, Eliopoulos GM (1984) Infection of the diabetic foot. In: Kozak GP, Hoar CS Jr., Rowbotham JL, Wheelock FC Jr, Gibbons GW, Campbell D (eds) Management of diabetic foot problems: Joslin Clinic and New England Deaconess Hospital. WB Saunders, Philadelphia, pp 97–102
LoGerfo FW, Coffman JD (1984) Vascular and microvascular disease of the foot. In diabetes: implications for foot care. N Engl J Med 311:1615–1619
Tur E, Yosipovitch G, Bar-On Y (1991) Skin reactive hyperemia in diabetic patients: a study by laser Doppler flowmetry. Diabet Care 14:958–962
Stevens MJ, Edmonds ME, Douglas SLE et al (1991) Influence of neuropathy on the microvascular response to local heating in the human diabetic foot. Clin Sci 80:249–256
Rendell M, Bamisedun O (1992) Diabetic cutaneous microangiopathy. Am J Med 93:611–618
Bornmyr S, Svensson H, Lilja B et al (1997) Cutaneous vasomotor responses in young type I diabetic patients. J Diabet Comp 11:21–26
Rayman G, Williams SA, Spencer PD et al (1986) Impaired microvascular response to minor skin trauma in type 1 diabetes. BMJ (Clin Res Ed) 292:1295–1298
Varani J, Dame MK, Rittie L et al (2006) Decreased collagen synthesis in chronologically aged skin: roles of age-dependent alterations in cellular aging and alterations in mechanical tension. Am J Pathol 168:1861–1868
Lateef H, Sevens M, Varani J (2004) All-trans retinoic acid suppresses matrix metalloproteinase production/activation and increases collagen synthesis in diabetic skin in organ culture. Am J Pathol 165:167–174
Teno S, Kanno H, Oga S et al (1999) Increased activity of membrane glycoprotein pc-1 in the fibroblasts from non-insulin-dependent diabetes mellitus patients with insulin resistance. Diabetes Res Clin Pract 45:25–30
Loots MA, Lamme EN, Mekkes JR et al (1999) Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 291:93–99
Wolff SP (1993) Diabetes mellitus and free radicals. Br Med Bull 49:642–652
Pop-Busui R, Sima AAF, Stevens MJ (2006) Diabetic neuropathy and oxidative stress. Diab Metab Res Rev 22(4):257–273
Tahrani AA, Askwith T, Stevens MJ (2010) Emerging drugs for diabetic neuropathy. Expert Opin Emerg Drugs 20(15):661–683
Pomposelli FB Jr, Jepsen SJ, Gibbons GW et al (1990) Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg 11:745–752
Rees RS, Smith DJ, Adamson B et al (1995) Oxidant stress: the role of the glutathione redox cycle in skin preconditioning. J Surg Res 58:395–400
Shukla A, Rasik A, Dhawan B (1999) Asiatic-induced elevation of antioxidant levels in healing wounds. Phythother Res 13:50
Wenk J, Foitzik A, Achterberg V et al (2001) Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 116:833–839
Allhorn M, Lundqvist K, Schmidtchen A et al (2003) Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol 121:640–646
James TJ, Hughes MA, Cherry GW et al (2003) Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 11:172–176
Yeoh-Ellerton S, Stacey MC (2003) Iron and 8-isoprostane levels in acute and chronic wounds. J Invest Dermatol 121:918–925
Wlaschek M, Scharffetter-Kochanek K (2005) Oxidative stress in chronic venous leg ulcers. Wound Repair Regen 13:452–461
Shukla A, Rasik AM, Patnaik GK (1997) Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound. Free Radic Res 26:93–101
Steiling H, Munz B, Werner S et al (1999) Different types of ROS-scavenging enzymes are expressed during cutaneous wound repair. Exp Cell Res 247:484–494
Wall IB, Moseley R, Baird DM et al (2008) J Invest Dermatol 128:2526–2540
Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247
Passos JF, Zglinicki T (2012) Mitochondrial dysfunction and cell senescence—skin deep into mammalian aging. Aging 4(2):74–75
Gurjala AN, Liu WR, Mogford JE et al (2005) Age-dependent response of primary human dermal fibroblasts to oxidative stress: cell survival, pro-survival kinases, and entrance into cellular senescence. Wound Repair Regen 13:565–575
Clarke RAF (2008) Oxidative stress and “senescent” fibroblasts in non-healing wounds as potential therapeutic targets. J Invest Dermatol 128:2361–2364
Shen H-M, Liu Z (2006) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 40:928–939
Wulf D (2002) Free radicals in regulation of physiological functions. Physiol Rev 82:47–95
Hellwig-Bürgel T, Stiehl DP, Wagner AE et al (2005) Hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25:297–310
Woodhouse BC, Dianov GL (2008) Poly ADP-ribose polymerase-1: an international molecule of mystery. DNA Repair (Amst) 7(7):1077–1086
Pacher P, Szabo C (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 25(3):235–260
Pacher P, Szabo C (2008) Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173(1):2–13
Vincent AM, Russell JW, Low P et al (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25(4):612–628
Feldman EL (2008) Diabetic neuropathy. Curr Drug Targets 9(1):1–2
Edwards JL, Vincent AM, Cheng HL et al (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120(1):1–34
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54(6):1615–1625
Du X, Matsumura T, Edelstein D et al (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112(7):1049–1057
Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97(22):12222–12226
Griffiths CE, Russman AN, Majmudar G (1993) Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 329:530–535
Varani J, Perone P, Fligiel SE et al (2002) Inhibition of type i procollagen production in photodamage: correlation between presence of high molecular weight collagen fragments and reduced procollagen synthesis. J Invest Dermatol 119:122–129
Brandner JM, Zacheja S, Houdek P et al (2008) Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation Into an ex vivo wound-healing model. Diabetes Care 31:114–120
Trengove NJ, Stacey MC, Macauley S et al (1999) Analysis of the acute and chronic wounds environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442–452
Wysocki AB, Staiano-Coico L, Grinnell F (1993) Wound fluid from chronic leg ulcers contain elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64–68
Yager DR, Zhang LY, Liang H et al (1996) Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 107:743–748
Yager DR, Stephen MC, Ward SI et al (1997) Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen 5:23–32
Bullen EC, Longaker MT, Updike DL et al (1995) Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104:236–240
Vaalamo M, Weckroth M, Puolakkainen P et al (1996) Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135:52–59
Muller M, Trocme C, Lardy B et al (2008) Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 25:419–426
Nwomeh BC, Liang HX, Cohen IK et al (1999) MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 81:189–195
Vaalamo M, Mattila L, Johansson N et al (1997) Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 109:96–101
Lobmann R, Ambrosch A, Schultz G et al (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45:1011–1016
Sibbald RG, Woo KY (2008) The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 24:S25–S30
Lobmann R, Schultz G, Lehnert H (2005) Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 28:461–471
Ladwig GP, Robson MC, Liu R et al (2002) Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 10:26–37
Trengove NJ, Bielefeldt-Ohmann H, Stacey MC (2000) Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 8:13–25
Piaggesi A, Viacava P, Rizzo L et al (2003) Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer. Diabetes Care 26:3123–3128
Chung JH, Seo JY, Choi HR et al (2001) Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol 117:1218–1224
Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363–9367
Chiba Y, Yamashita Y, Ueno M et al (2005) Cultured murine dermal fibroblast-like cells from senescence-accelerated mice as in vitro models for higher oxidative stress due to mitochondrial alterations. J Gerontol A Biol Sci Med Sci 60:1087–1098
Song YS, Lee BY, Hwang ES (2005) Distinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis. Mech Ageing Dev 126:580–590
Wall SJ, Sampson MJ, Levell N et al (2003) Elevated matrix metalloproteinase-2 and n-3 production from human diabetic dermal fibroblasts. Br J Dermatol 149:13–16
Price SA, Agthong S, Middlemas AB et al (2004) Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase. Diabetes 53:1851–1856
Purves T, Middlemas A, Agthong S et al (2001) A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15:2508–2514
Brenneisen P, Wenk J, Klotz LO et al (1998) J Biol Chem 273:5279–5287
Fisher GJ, Talwar HS, Lin JY et al (1998) J Clin Invest 101:1432–1440
Fisher GJ, Quan T, Purohit T et al (2009) Collagen fragmentation promotes oxidative stress and elevated matrix metalloproteinase-1 in fibroblasts in aged human skin. Am J Pathol 174:101–114
Varani J, Warner RL, Gharaee-Kermani M et al (2000) Vitamin a antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 114:480–486
Zaw KK, Yokoyama Y, Abe M et al (2006) Catalase restores the altered mRNA expression of collagen and matrix metalloproteinases by dermal fibroblasts exposed to reactive oxygen species. Eur J Dermatol 16:375–379
Choi MS, Yoo MS, Son DJ et al (2007) Increase of collagen synthesis by obovatol through stimulation of the TGF-β signaling and inhibition of matrix metalloproteinase in UVB-irradiated human fibroblast. J Dermatol Sci 46:127–137
Desfalts AC, Serri O, Renier G (1998) Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 21:487–493
Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1 beta and tumor necrosis-factor-alpha decrease collagen synthesis and increased matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259–1265
Gao C-F, Wang H, Wang A-H et al (2004) Transcriptional regulation of human a1(I) procollagen gene in dermal fibroblasts. World J Gastroenterol 10:1447–1451
Levenson SM, Demetriou AA (1992) Metabolic factors. In: Cohen IK, Diegelmann RF, Lindblad WJ (eds) Wound healing: biochemical and clinical aspects. W.B. Saunders, Philadelphia, pp 248–273
Varani J, Perone P, Griffiths CEM et al (1994) All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. J Clin Invest 94:1747–1753
Varani J, Perone P, Fligiel SEG et al (1994) All-trans retinoic acid preserves viability of fibroblasts and keratinocytes in full-thickness human skin and fibroblasts in isolated dermis in organ culture. Arch Dermatol Res 1994(286):443–447
Guzik TJ, Mussa S, Gastaldi D et al (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656–1662
Frank S, Kampfer H, Wetzler C et al (2002) Nitric oxide drives skin repair: novel function of an established mediator. Kidney Int 61:882–888
Ziche M, Morbidelli L, Masini E et al (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036–2044
Schaffer MR, Efron PA, Thornton FJ et al (1997) Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 158:2375–2381
Noiri E, Peresleni T, Srivastava N et al (1996) Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am J Physiol 170:C794–C802
Witte MB, Thornton FJ, Tantry U et al (2002) l-arginine supplementation enhances diabetic wound healing: involvement of the nitric oxide synthase and arginase pathways. Metabolism 51:1269–1273
Yu Y, Thorpe SR, Jenkins AJ et al (2006) Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia 49:2488–2498
Wear-Maggitti K, Lee J, Conejero A et al (2004) Use of topical sRAGE in diabetic wounds increased neovascularization and granulation tissue formation. Ann Plast Surg 52:519–522
Meerwaldt R, Links TP, Graaff R et al (2005) Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 48:1637–1644
Schmidt AM, Shi DY, Shi FY et al (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949–955
Schmidt AM, Yan SD, Wautier JL et al (1994) Activation of receptor for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 10:1521–1528
Owen WF, Hou FF, Ro S et al (1998) Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Kidney Int 53:1365–1373
Cibrian D, Guillen I, Freyre F et al (2005) Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci 109:83–95
Ilnytska O, Lyzogubov VV, Stevens MJ et al (2006) PARP inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55:1686–1694
Moncada S, Gryglewski RJ, Bunting S et al (1976) A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins 12:715–737
Kellogg AP, Wiggin T, Larkin D et al (2007) Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fibers loss in long term experimental. Diabetes 56:2997–3005
Ward KK, Low PA, Schmelzer JD et al (1989) Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112:197–208
Tur E, Yosipovitch G, Bar-On Y (1991) Skin reactive hyperemia in diabetic patients: a study by laser Doppler flowmetry. Diabetes Care 14:958–962
Bornmyr S, Svensson H, Lilja B et al (1997) Cutaneous vasomotor responses in young type I diabetic patients. J Diabetes Complicat 11:21–26
Rayman G, Williams SA, Spencer PD et al (1986) Impaired microvascular response to minor skin trauma in type 1 diabetes. Br Med J (Clin Res Ed) 292:1295–1298
Vinik AI, Holland MT, Le Beau JM et al (1992) Diabetic neuropathies. Diabetes Care 12:1926–1975
Feldman EL, Stevens MJ, Russell JW (2003) Diabetic peripheral and autonomic neuropathy. In: Sperling MA (ed) Contemporary endocrinology: type I diabetes: etiology and treatment. Humana, Totowa, pp 437–461
Anand P, Terenghi G, Warner G et al (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2:703–707
Fromy B, Abraham P, Bouvet C et al (2002) Early decrease of skin blood flow in response to locally applied pressure in diabetic subjects. Diabetes 51:1214–1217
Fromy B, Merzeau S, Abraham P et al (2000) Mechanisms of the cutaneous vasodilator response to local external pressure application in rats: involvement of CGRP, neurokinins, prostaglandins and NO. Br J Pharmacol 131:1161–1171
Sigaudo-Roussel D, Demiot C, Fromy B et al (2004) Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice. Diabetes 53:1564–1569
Habuchi O, Miyachi T, Kaigawa S et al (1991) Effects of glutathione depletion on the synthesis of proteoglycan and collagen in cultured chondrocytes. Biochim Biophys Acta 1093:153–161
Young MJ, Marshall A, Adams JE et al (1995) Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 18:34–38
Stevens MJ, Edmonds ME, Foster AVM et al (1992) Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 35:148–154
Shapiro SA, Stansberry KB, Hill MA et al (1998) Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabet Comp 12:147–153
Witzke KA, Vinik AI, Grant LM et al (2011) Loss of RAGE defense: a cause of Charcot neuroarthropathy? Diabetes Care 34:1617–1621
Mabilleau G, Petrova NL, Edmonds ME et al (2008) Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 51:1035–1040
Tahrani A, Zeng W, Shakher J et al (2012) Cutaneous structural and functional correlates of foot complications in high risk subjects. Diabetes Care 35:1913
Varani J, Perone P, Merfert MG et al (2002) All-trans retinoic acid improves structure and function of diabetic rat skin in organ culture. Diabetes 51:3510–3516
Zeng W, Tahrani A, Shakher J et al (2011) Effect of a synthetic retinoid on matrix metalloproteinases, procollagen expression and antioxidant defence enzymes in cultured human dermal fibroblasts exposed to high glucose. J Diab Comp 25:398–404
Ciaccio M, Valenza M, Tesoriere L et al (1993) Vitamin A inhibits doxorubicin-induced membrane lipid peroxidation in rat tissues in vivo. Arch Biochem Biophys 302:103–108
Palacios A, Piergiacomi VA, Catala A (1996) Vitamin A supplementation inhibits chemiluminescence and lipid peroxidation in isolated rat liver microsomes and mitochondria. Mol Cell Biochem 154(1):77–82
Jackson B, Morgan K, Werrbach-Perez et al (1991) Antioxidant effect of retinoic acid on PC 12 rat pheochromocytoma cells. Int J Dev Neurosci 9
Ahlemeyer B, Bauerbach E, Plath M et al (2001) Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med 30:1067–1077
Ahlemeyer B, Krieglstein J (2000) Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis. Neurochem Int 36:1–5
Kitamura M, Ishikawa Y, Moreno-Manzano V et al (2002) Intervention by retinoic acid in oxidative stress-induced apoptosis. Nephrol Dial Transplant 17(Suppl 9):84–87
Chai D, Wang B, Shen L et al (2008) RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic Biol Med 44:1334–1347
Guleria RA, Pan J, DiPete D et al (2006) Hyperglycemia inhibits retinoic acid-induced activation of Rac1, prevents differentiation of cortical neurons, and causes oxidative stress in a rat model of diabetic pregnancy. Diabetes 55:3334
Yoo HY, Chang MS, Rho HM (1999) Induction of Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234:87–91
Dal-Pizzol F, Klamt F, Benfato MS et al (2001) Retinol supplementation induces oxidative stress and modulates antioxidant enzyme activities in rat sertoli cells. Free Radic Res 34:395–404
Murata M, Kawanishi S (2000) Oxidative DNA damage by vitamin A and its derivative via superoxide generation. J Biol Chem 275:2003–2008
Gimeno A, Zaragoza R, Vivo-Ses I et al (2004) Retinol at concentrations greater than the physiological limit induces oxidative stress and apoptosis in human dermal fibroblasts. Exp Dermatol 13:45–54
Packer L, Witt EH, Tritschler HJ (1995) Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227–250
Stevens MJ, Obrosova I, Cao X et al (2000) Effects of DL–lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 1006–1015
Ziegler D, Hanefeld M, Ruhnau KJ et al (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid—a 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38:1425–1433
Ziegler D, Hanefeld M, Ruhnau KJ et al (1999) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (aladin iii study). Aladin iii study group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care 22:1296–1301
Ziegler D, Ametov A, Barinov A et al (2006) Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29:2365–2370
Schmidt AM (1996) Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J Clin Invest 97:238–243
hang W-J, Frei B (2001) α-Lipoic acid inhibits TNF-α-induced NF-kB activation and adhesion molecule expression in human endothelial cells. FASEB J 15:2423–2432
Demiot C, Fromy B, Saumet JL et al (2006) Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice. Cardiovasc Res 69:245–252
Haak E, Usadel KH, Kusterer K et al (2000) Effects of alpha-lipoic acid on the microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes 108:168–174
Schleicher ED, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457–468
Li F, Abatan OI, Kim H et al (2006) Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol Dis 22:669–676
Lateef H, Aslam MN, Stevens MJ et al (2005) Pretreatment of diabetic rats with lipoic acid improves healing of subsequently-induced abrasion wounds. Arch Dermatol Res 297:75–83
Luo J-D, Wang Y-Y, Fu W-L et al (2004) Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 110:2484–2493
Goova MT, Li J, Kislinger T et al (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:513–525
Galeano M, Torre V, Deodato B et al (2001) Raxofelast, a hydrophilic vitamin E-like antioxidant, stimulates wound healing in genetically diabetic mice. Surgery 129:467–477
Stevens MJ, Hosaka Y, Masterson JA et al (1999) Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells. Am J Physiol 277:E760–E771
Li F, Obrosova IG, Abatan O et al (2005) Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of streptozotocin-diabetic rats. Am J Physiol 2995(288):E29–E36
Davidson N, Southwick CA (1971) Amino acids and presynaptic inhibition in the rat cuneate nucleus. J Physiol 219:689–708
Obrosova IG, Fathallah L, Stevens MJ (2001) Taurine counteracts oxidative stress and nerve growth factor deficits in early experimental diabetic neuropathy. Exp Neurol 172:211–219
Aruoma OI, Halliwell B, Hoey BM et al (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256:251–255
Obrosova IG, Stevens MJ (1999) Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation and energy metabolism in diabetic precataractous lens. Invest Opthalmol Vis Sci 40:680–688
Trachtman H, Futterweit S, Prenner J et al (1994) Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells. Biochem Biophys Res Commun 199:346–352
Janeke G, Siefken W, Carstensen S et al (2003) Role of taurine accumulation in keratinocyte hydration. J Invest Dermatol 121:354–361
Lobo MV, Alonso FJ, Latorre A et al (2001) Taurine levels and localisation in the stratified squamous epithelia. Histochem Cell Biol 115:341–347
Degim Z, Çelebi N, Sayan H et al (2002) An investigation on skin wound healing in mice with a taurine–chitosan gel formulation. Amino Acids 22:187–198
Asquith T, Zeng W, Eggo M et al (2009) Oxidative stress and dysregulation of the human taurine transporter in high glucose exposed Schwann cells: implications for the pathogenesis of diabetic neuropathy. Am J Physiol Endocrinol Metab 297:E620–E628
Grafe F, Wohlrab W, Neubert RH et al (2004) Functional characterization of sodium- and chloride-dependent taurine transport in human keratinocytes. Eur J Pharm Biopharm 57:337–341
Young CN, Koepke JI, Terlecky LJ et al (2008) Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 128:2606–2614
Nandhini TA, Thirunavukkarasu V, Ravichandran MK et al (2005) Taurine prevents fructose-diet induced collagen abnormalities in rat skin. J Diab Comp 19:305–311
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stevens, M.J., Shakher, J. (2014). Oxidative Stress and Complications of the Diabetic Foot. In: Obrosova, I., Stevens, M., Yorek, M. (eds) Studies in Diabetes. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4899-8035-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-8035-9_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4899-8034-2
Online ISBN: 978-1-4899-8035-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)